AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27339806
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg folic acid, 25 mg Vitamin B6, and Vitamin B12
Trial: 20625068
Drug: Intramuscular interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular interferon beta‐1a (30 micrograms once weekly for 2 years)
Trial: 20625068
Drug: Placebo (once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (once weekly for 2 years)
Trial: 18565107
Drug: Levetiracetam (3000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levetiracetam (3000 mg/day)
Trial: 11791150
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of sucrose (2160 kJ, 575 ml)
Trial: 11791150
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of maltose (2160 kJ, 575 ml)
Trial: 11791150
Drug: Water control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water control (67 kJ, 575 ml)
Trial: 11791150
Drug: Intragastric infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intragastric infusion of sucrose
Trial: 11791150
Drug: Intragastric infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intragastric infusion of maltose
Trial: 2178534
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of warfarin, beginning 3 days before catheter insertion and continuing for 90 days
Trial: 8423275
Drug: Intranasal beclomethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal beclomethasone dipropionate
Trial: 31272930
Drug: Semaglutide once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semaglutide once weekly
Trial: 21258206
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with percutaneous microwave ablation (PMWA) and adoptive immunotherapy
Trial: 17331963
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide 800 microg/day
Trial: 16371870
Drug: MMR Berna
RxNorm normalized name: varicella-zoster virus vaccine live (Oka-Merck) strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMR Berna vaccine
Trial: 16371870
Drug: Licensed vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Licensed vaccine M-M-R-Vax (Merck & Co.)
Trial: 12526191
Drug: Bovine-derived bone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bovine-derived bone protein extract with 12.5 micrograms/mg DFDBA
Trial: 12526191
Drug: Bovine-derived bone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bovine-derived bone protein extract with 25.0 micrograms/mg DFDBA
Trial: 9594863
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no NO treatment)
Trial: 7879322
Drug: Intraurethral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraurethral administration of prostaglandin E1
Trial: 7879322
Drug: Intracavernous administration
RxNorm normalized name: bivalirudin
DrugBank: Bivalirudin (DB00006)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracavernous administration of half the dose of prostaglandin E1
Trial: 227069
Drug: econazole-triamcinolon combination
RxNorm normalized name: econazole / triamcinolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: econazole-triamcinolon combination
Trial: 19014837
Drug: LC15-0444 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LC15-0444 200 mg
Trial: 20002082
Drug: LC15-0444 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LC15-0444 400 mg
Trial: 19014837
Drug: LC15-0444 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LC15-0444 600 mg
Trial: 10807761
Drug: Hormone replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone replacement therapy (HRT) with 2 mg estradiol + 1 mg norethisterone
Trial: 8923067
Drug: PCA with
RxNorm normalized name: lauryl PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCA with dipyrone (initially 2.0 g i.v. and 1.0 g/2 ml i.v. at 4, 8 and 16 h)
Trial: 1366330
Drug: Alginete pills
RxNorm normalized name: sodium alginate Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alginete pills with diet
Trial: 28957833
Drug: Clear Care
RxNorm normalized name: Clear care plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clear Care (CC)
Trial: 25335348
Drug: Topical 0.05%
RxNorm normalized name: ingenol topical 0.05% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 0.05% clobetasol proprionate lotion
Trial: 20576091
Drug: Lisdexamfetamine dimesylate
RxNorm normalized name: Lisdexamfetamine Dimesylate
DrugBank: Lisdexamfetamine (DB01255)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lisdexamfetamine dimesylate (LDX) 30‐70 mg/d
Trial: 16061764
Drug: Pharmacotherapy (paroxetine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacotherapy (paroxetine hydrochloride or bupropion hydrochloride)
Trial: 2667400
Drug: Triazolam (0.125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam (0.125 mg)
Trial: 11949768
Drug: Ethanol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (0.5 g/kg) + Triazolam
Trial: 11949768
Drug: Ethanol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (0.5 g/kg) + Temazepam
Trial: 10780808
Drug: Ethanol (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (0 g/kg)
Trial: 10349927
Drug: bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 0.25% (0.7 ml x kg(‐1)) via lumbar epidural block
Trial: 7572122
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine injection (1 mg/kg)
Trial: 795441
Drug: Colestipol HCl
RxNorm normalized name: colestipol HCl
DrugBank: Colestipol (DB00375)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Colestipol HCl 10 g twice daily
Trial: 28461256
Drug: Veliparib (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Veliparib (120 mg) with carboplatin/paclitaxel
Trial: 20650587
Drug: 25-s injection
RxNorm normalized name: (S)-2,5-Diaminopentanoate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25-s injection duration
Trial: 20650587
Drug: 35-s injection
RxNorm normalized name: TPG-S
DrugBank: Tocofersolan (DB11635)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 35-s injection duration
Trial: 22298019
Drug: Transdermal GTN
RxNorm normalized name: GTN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal GTN (0.6 mg/h) for 2 h a day for 6 days
Trial: 22298019
Drug: Oral PETN
RxNorm normalized name: Pentaerythritol tetranitrate
DrugBank: Pentaerythritol tetranitrate (DB06154)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral PETN (80 mg) once a day for 6 days
Trial: 15900289
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg AZD3582
Trial: 15900289
Drug: 1500 mg
RxNorm normalized name: inulin 1500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg AZD3582
Trial: 12357161
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg rofecoxib
Trial: 12576917
Drug: Arm A:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm A: three 8‐mg doses of ondansetron intravenously at 4‐hour intervals plus dexamethasone 20 mg intravenously from the start of chemotherapy, followed by dexamethasone 5 mg intravenously every 12 hours.
Trial: 12576917
Drug: Arm B:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm B: three 8‐mg doses of ondansetron intravenously at 24‐hour intervals plus dexamethasone as in Arm A.
Trial: 12576917
Drug: Female patients
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Female patients during chemotherapy cycles.
Trial: 9609084
Drug: Abciximab treatment
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Abciximab treatment
Trial: 9609084
Drug: Abciximab with
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Abciximab with standard-dose heparin
Trial: 2760974
Drug: Rice powder
RxNorm normalized name: White rice powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rice powder electrolyte solution
Trial: 12715722
Drug: Anakinra (recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra (recombinant IL-1 receptor antagonist) with or without methotrexate
Trial: 29795141
Drug: PSA 2.5-4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PSA 2.5-4 ng/mL
Trial: 29795141
Drug: PSA 4.1-6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PSA 4.1-6 ng/mL
Trial: 29795141
Drug: PSA 6-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PSA 6-10 ng/mL
Trial: 23713767
Drug: Oral moxifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral moxifloxacin 400 mg in fed state
Trial: 23713767
Drug: Oral moxifloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral moxifloxacin 400 mg in fasted state
Trial: 22573670
Drug: English words
FDA approved: no
EMA approved: no
PMDA approved: no
Description: English words with negative valence (e.g., 'violence')
Trial: 22573670
Drug: English words
FDA approved: no
EMA approved: no
PMDA approved: no
Description: English words with positive and neutral valence (e.g., 'holiday', 'theory')
Trial: 20536509
Drug: Resistant starch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistant starch (40 g/day)
Trial: 20536509
Drug: Placebo supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo supplement (0 g/day)
Trial: 17969366
Drug: Perindopril 2
RxNorm normalized name: perindopril 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril 2 mg/Indapamide 0.625 mg
Trial: 7917797
Drug: Cefuroxime axetil
RxNorm normalized name: Cefuroxime Axetil
DrugBank: Cefuroxime (DB01112)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefuroxime axetil 250 mg twice daily
Trial: 10463514
Drug: Amoxicillin/clavulanate 500/125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate 500/125 mg 3 times daily
Trial: 2562010
Drug: Fluxum (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluxum (low molecular weight heparin)
Trial: 2562010
Drug: Calcium-heparin
RxNorm normalized name: HEPARIN CALCIUM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium-heparin
Trial: 853979
Drug: bivalent iron
RxNorm normalized name: Iron bivalent, oral preparations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bivalent iron sulfate (quick release stick capsule preparation)
Trial: 853979
Drug: trivalent iron
RxNorm normalized name: Iron trivalent, oral preparations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: trivalent iron citrate complex preparations
Trial: 853979
Drug: ferric iron
RxNorm normalized name: FERRIC IRON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ferric iron preparations
Trial: 28735202
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no exercise therapy)
Trial: 25926562
Drug: Intra-myocardial injections
RxNorm normalized name: somatropin
DrugBank: Somatotropin (DB00052)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intra-myocardial injections of MSC
Trial: 17328961
Drug: Intensive group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive group cognitive therapy (IGCT)
Trial: 21763101
Drug: Intensive group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive group cognitive therapy (IGCT) and Individual cognitive therapy (ICT)
Trial: 16786421
Drug: EmbryoGlue treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EmbryoGlue treatment prior to embryo transfer
Trial: 14557172
Drug: Oral acetylsalicylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral acetylsalicylate
Trial: 14557172
Drug: Oral pentoxifylline
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral pentoxifylline
Trial: 14557172
Drug: Topical beta-blocker
RxNorm normalized name: Beta-HC Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical beta-blocker
Trial: 8639370
Drug: Smoking reduction
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smoking reduction advice in combination with dental health instruction and periodontal care
Trial: 6234335
Drug: Topical 4%
RxNorm normalized name: menthol topical 4% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 4% erythromycin/1.2% zinc acetate solution
Trial: 31295391
Drug: Hydrofluoric acid
RxNorm normalized name: Hydrofluoric acid
DrugBank: Hydrogen fluoride (DB11072)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrofluoric acid treatment [9.6% HF (Pulpdent) for 2 minutes]
Trial: 29864437
Drug: Partial gland
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Partial gland ablation with vascular targeted photodynamic therapy
Trial: 25777270
Drug: Cognitive intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive intervention (two weekly 1-hour therapy sessions)
Trial: 25176361
Drug: Gabapentin 300
RxNorm normalized name: gabapentin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 300 mg orally one hour before surgery and then every 12 hours for the first 24 hours after surgery
Trial: 22488231
Drug: 65 g/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 65 g/L carbohydrate (trial C)
Trial: 22488231
Drug: 50 g/L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g/L carbohydrate and 15 g/L whey protein isolate (trial CP)
Trial: 12161513
Drug: Metyrapone treatment
RxNorm normalized name: Metyrapone
DrugBank: Metyrapone (DB01011)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metyrapone treatment followed by hydrocortisone replacement in elderly subjects with moderate cortisol levels (n = 8)
Trial: 12161513
Drug: Hydrocortisone treatment
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone treatment in elderly subjects with high cortisol levels (n = 9)
Trial: 12161513
Drug: Metyrapone treatment
RxNorm normalized name: Metyrapone
DrugBank: Metyrapone (DB01011)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metyrapone treatment in elderly subjects with high cortisol levels (n = 9)
Trial: 8558936
Drug: IL-3 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-3 (all doses combined)
Trial: 8558936
Drug: Adverse events
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adverse events during IL-3 and chemotherapy
Trial: 6341045
Drug: Cefaclor 500
RxNorm normalized name: cefaclor 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor 500 mg three times daily for seven days
Trial: 6341045
Drug: Amoxicillin 750
RxNorm normalized name: amoxicillin 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin 750 mg three times daily for seven days
Trial: 28904319
Drug: Low-molecular-weight chitosan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight chitosan solution
Trial: 15262418
Drug: Nystatin suspension
RxNorm normalized name: Nystatin
DrugBank: Nystatin (DB00646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nystatin suspension
Trial: 16680252
Drug: tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: tranexamic acid (10 mg x kg(‐1))
Trial: 10862158
Drug: rhDNase (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhDNase (2.5 mg qd)
Trial: 9322569
Drug: Oral thiamine
RxNorm normalized name: thiamine Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral thiamine (10 mg/d)
Trial: 8383578
Drug: Aspirin at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin at 1 g/day
Trial: 29376886
Drug: scalp acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: scalp acupuncture + low frequency rTMS + routine rehabilitation treatment
Trial: 29376886
Drug: scalp acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: scalp acupuncture + routine rehabilitation treatment
Trial: 26803187
Drug: Intensity Modulated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensity Modulated Radiotherapy (IMRT) and Concomitant Chemotherapy (CCT)
Trial: 19013300
Drug: Glucose (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose (25 g)
Trial: 20533761
Drug: Loratadine/montelukast (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratadine/montelukast (10 mg/10 mg)
Trial: 11297959
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (30 mg daily elemental zinc)
Trial: 7509243
Drug: Terazosin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terazosin (1 to 10 mg once daily for 24 weeks)
Trial: 7509243
Drug: Placebo (once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (once daily for 24 weeks)
Trial: 3080693
Drug: TRH 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRH 150 mg subcutaneous injection
Trial: 3080693
Drug: TRH 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TRH 500 mg IV infusion
Trial: 29987899
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (Control Group E)
Trial: 27133819
Drug: ATRA and
RxNorm normalized name: ATRA
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ATRA and chemotherapy (CHT)
Trial: 24497338
Drug: Antiarrhythmic Drugs
RxNorm normalized name: ANTIARRHYTHMICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiarrhythmic Drugs (AAD)
Trial: 22064737
Drug: Avilamycin (44
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avilamycin (44 mg/kg)
Trial: 22064737
Drug: Rosemary essential
RxNorm normalized name: EUCALYPTOL 2.4 g in 100 g TOPICAL LIQUID [MELAO ROSEMARY ESSENTIAL Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosemary essential oil (100 mg/kg)
Trial: 22064737
Drug: Oregano essential
RxNorm normalized name: Oregano
DrugBank: Oregano (DB10677)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oregano essential oil (100 mg/kg)
Trial: 22064737
Drug: Rosemary and
RxNorm normalized name: Aspercreme Max Strength-Lidocaine Rosemary and Mint Roll-On
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosemary and oregano essential oils (50 mg each/kg)
Trial: 22064737
Drug: Commercial blend
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercial blend of essential oils (1,000 mg/kg)
Trial: 11218894
Drug: Group 1:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 1: 10% glucose 500 ml + danshen compound 14 ml + low molecular weight dextran 500 ml i.v.
Trial: 11218894
Drug: Group 2:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 2: 10% glucose 500 ml + danshen compound 14 ml + low molecular weight dextran 500 ml i.v. + 25% magnesium sulfate 20 ml in 5% glucose 500 ml i.v.
Trial: 11218894
Drug: Group 3:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 3: no treatment given.
Trial: 3034017
Drug: Ramipril 2.5
RxNorm normalized name: ramipril 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 2.5 mg once daily
Trial: 8458057
Drug: Placebo 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo 2.5 mg once daily
Trial: 2957124
Drug: Upper arm
RxNorm normalized name: A And D Medical UA-651 Upper Arm BPM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Upper arm injection of 20 micrograms LHRH
Trial: 2957124
Drug: Lower abdominal
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower abdominal wall injection of 20 micrograms LHRH
Trial: 2957124
Drug: Order of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Order of injections (upper arm first vs lower abdominal wall first)
Trial: 28577666
Drug: 6-month dual
RxNorm normalized name: leuprolide
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6-month dual antiplatelet therapy (DAPT) after Resolute Integrity stent implantation
Trial: 29104179
Drug: 12-month dual
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 12-month dual antiplatelet therapy (DAPT)
Trial: 19027814
Drug: Trilucent breast
RxNorm normalized name: chicken breast preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trilucent breast implants (TBI)
Trial: 3584738
Drug: Linoleic acid
RxNorm normalized name: Linoleic acid
DrugBank: Linoleic acid (DB14104)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linoleic acid (23 g/d for 4 weeks)
Trial: 3584738
Drug: Oleic acid
RxNorm normalized name: Oleic Acid
DrugBank: Oleic Acid (DB04224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oleic acid (23 g/d for 4 weeks)
Trial: 29669883
Drug: Erythromycin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (400 mg, twice daily for 48 weeks)
Trial: 28854973
Drug: CCH 0.40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCH 0.40 mg
Trial: 28854973
Drug: CCH 0.60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCH 0.60 mg
Trial: 28854973
Drug: CCH 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CCH 0.25 mg